Collectively, the VASN‐modulated signaling pathways appear to play a crucial role in mitigating adverse cardiovascular remodeling, including arterial thickening/stiffening and cardiac hypertrophy/stiffening, potentially preventing the development of cardiovascular diseases such as hypertension, atherosclerosis, and heart failure (Figure 6). The gene discussed is VASN; the disease is cardiac hypertrophy.